TuHURA Biosciences (HURA) Other Non Operating Income (2012 - 2026)
TuHURA Biosciences (HURA) posted quarterly Other Non Operating Income of -$6699.0 for Q1 2026, down 101.9% year-over-year from $352652.0 in Q1 2025, and down 100.47% quarter-over-quarter from $1.4 million in Q4 2025.
TuHURA Biosciences (HURA) Other Non Operating Income (2012 - 2026) Analysis & Trends
TuHURA Biosciences' Other Non Operating Income history runs 15 years deep, the most recent figure standing at -$6699.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 101.9% year-over-year to -$6699.0; the TTM figure through Mar 2026 stood at $1.4 million (up 125.18% YoY), while the FY2025 annual figure was $1.7 million, up 143.24% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$6699.0, down from $1.4 million in the prior quarter.
- The five-year high for Other Non Operating Income was $1.4 million in Q4 2025, with the low at -$3.7 million in Q3 2024.
- The 5-year median for Other Non Operating Income is -$1500.0 (2023), against an average of -$293486.6.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income tumbled 186489.45% in 2024, then jumped 249.18% in 2025.
- TuHURA Biosciences' Other Non Operating Income stood at $11000.0 in 2022, then tumbled by 172.73% to -$8000.0 in 2023, then plunged by 46547.36% to -$3.7 million in 2024, then surged by 137.84% to $1.4 million in 2025, then tumbled by 100.47% to -$6699.0 in 2026.
- Business Quant data shows HURA's Other Non Operating Income at -$6699.0 in Q1 2026, $1.4 million in Q4 2025, and -$372852.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | TuHURA Biosciences | 37.61 Mn | 37.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,699.00 |
| Dec 31, 2025 | 1.41 Mn |
| Sep 30, 2025 | -372,852.00 |
| Jun 30, 2025 | 352,121.00 |
| Mar 31, 2025 | 352,652.00 |
| Sep 30, 2024 | -3.73 Mn |
| Jun 30, 2024 | -1.88 Mn |
| Mar 31, 2024 | -236,388.00 |
| Dec 31, 2023 | -8,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Sep 30, 2022 | 11,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | -9,000.00 |
| Mar 31, 2021 | -1,000.00 |
| Dec 31, 2020 | -3,000.00 |
| Sep 30, 2020 | 1,000.00 |